NCT05630092 is a NA clinical trial of Maximal 6-minute Walk Test (Max_6MWT) in Respiratory Disease, sponsored by Hampshire Hospitals NHS Foundation Trust.

Who is sponsoring NCT05630092?

NCT05630092 is sponsored by Hampshire Hospitals NHS Foundation Trust.

What drugs are being tested in NCT05630092?

Interventions in NCT05630092: Maximal 6-minute Walk Test (Max_6MWT), Normal speed 6-minute Walk Test (Nor_6MWT).

What condition does NCT05630092 study?

NCT05630092 studies Respiratory Disease.

Is NCT05630092 still recruiting?

NCT05630092 is currently completed. Last updated 27 November 2024.

Last reviewed 2024-11-27 · How we verify

NCT05630092

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparing 6-Minute Walk Tests for Ambulatory Oxygen Assessment

Completed NA Last updated 27 November 2024

What this trial tests

NA trial testing Maximal 6-minute Walk Test (Max_6MWT) in Respiratory Disease in 93 participants. Completed in 1 May 2024.

Timeline

1 January 2023

Primary endpoint
23 February 2024

1 May 2024

Quick facts

Lead sponsor	Hampshire Hospitals NHS Foundation Trust
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	single
Primary purpose	health services research
Enrollment	93
Start date	1 January 2023
Primary completion	23 February 2024
Estimated completion	1 May 2024
Sites	1 location across United Kingdom

Drugs / interventions tested

Maximal 6-minute Walk Test (Max_6MWT)
Normal speed 6-minute Walk Test (Nor_6MWT)

Conditions studied

Respiratory Disease — all drugs for Respiratory Disease →

Sponsor

Hampshire Hospitals NHS Foundation Trust

Who can join

Adults 18 to 90, any sex, with Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with lung disease who report breathlessness on exertion are often referred for a 6MWT. Due to the nature of the 6MWT (hereon referred to as a Max-6MWT), patients are required to walk as far as they can in 6 minutes. This may lead to an inaccurate assessment of their requirement for ambulatory oxygen as this form of exercise may not correspond to their normal daily activities. In this study, patients who are routinely referred for a Max-6MWT to investigate possible exercise-induced hypoxaemia will be invited to perform an additional walking test which is performed at their normal walking speed, referred here on in as a Nor\_6MWT. We hypothesise that performing a Nor\_6MWT will provide a more accurate assessment of a patients' oxygen requirement, primarily from their oxygen desaturation during the test.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Respiratory Disease

Currently open trials in the same condition.

NCT06716502 — A New Portable Device for Non-invasive Ventilatory Support · NA · recruiting
NCT06455033 — Manual Diaphragm Release on Stepping Reaction Time in Chronic Obstructive Pulmonary Disease · NA · active not recruiting
NCT06796894 — Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics · recruiting
NCT06503913 — Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder · NA · active not recruiting
NCT06569940 — Sleepiz One+ vs. Capnography and Electrocardiography · NA · recruiting

Other Hampshire Hospitals NHS Foundation Trust trials

Trials by the same sponsor.

NCT03995797 — VESPER: Pelvic Organ Prolapse Study · NA · withdrawn
NCT03996070 — VESPER: Stress Urinary Incontinence STUDY · NA · completed
NCT05718726 — Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI) · recruiting
NCT03861260 — GAG Replacement vs URethral DIlAtatioN · NA · withdrawn
NCT03317145 — Lower Limb Blood Flow Geko vs Foot Pump · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05630092 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hampshire Hospitals NHS Foundation Trust
Last refreshed: 27 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05630092.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing